Stocks / Screens / Small-Cap Growth Stocks in the US Market

Small-Cap Growth Stocks in the US Market (2026)

Companies under $2B in market value compounding revenue 15%+ a year with positive free cash flow — fast growers that are also self-funding. 58 companies qualify today — top 25 below, recomputed nightly from SEC filings.

Small-cap growth is where the biggest multi-year winners often start, but it is also where cash-burning stories hide. This screen looks for US companies under $2 billion in market capitalisation growing revenue at least 15% a year over the last five fiscal years, and — unusually for a growth screen — requires positive free cash flow, so the list leans toward businesses funding their own expansion rather than the market’s. Everything is computed from filed statements, not projections. Smaller companies carry more single-stock risk and thinner liquidity, so treat this as a research starting point, and read the margin column to see which growers are actually profitable.

Company	Rev growth (5y)	Net margin	Market cap
1. Orrstown Financial Services, Inc. (ORRF)	72.1%/yr	32.5%	$758.11M
2. Capitol Federal Financial, Inc. (CFFN)	68.5%/yr	33.8%	$1.00B
3. Central Pacific Financial Corp. (CPF)	65.3%/yr	26.4%	$941.99M
4. TriCo Bancshares (TCBK)	61.0%/yr	29.6%	$1.67B
5. Civista Bancshares, Inc. (CIVB)	58.6%/yr	27.2%	$554.08M
6. Acacia Research Corporation (ACTG)	57.1%/yr	7.6%	$449.62M
7. Independent Bank Corporation (IBCP)	55.5%/yr	31.4%	$718.95M
8. Camden National Corporation (CAC)	55.0%/yr	26.2%	$871.95M
9. Carter Bankshares, Inc. (CARE)	52.6%/yr	21.0%	$655.10M
10. Bar Harbor Bankshares (BHB)	46.8%/yr	21.9%	$609.91M
11. Tompkins Financial Corporation (TMP)	46.8%/yr	36.0%	$1.30B
12. Southern First Bancshares, Inc. (SFST)	42.9%/yr	25.7%	$570.71M
13. Distribution Solutions Group, Inc. (DSGR)	41.3%/yr	0.4%	$1.26B
14. NETSTREIT Corp. (NTST)	40.0%/yr	3.8%	$2.00B
15. City Holding Company (CHCO)	38.8%/yr	41.1%	$1.82B
16. Astrana Health, Inc. (ASTH)	35.9%/yr	0.7%	$1.89B
17. Ridgepost Capital, Inc (RPC)	34.6%/yr	6.6%	$888.40M
18. ANI Pharmaceuticals, Inc. (ANIP)	33.5%/yr	8.7%	$1.85B
19. Mama's Creations, Inc. (MAMA)	33.3%/yr	3.1%	$587.80M
20. GigaCloud Technology Inc. (GCT)	32.8%/yr	10.6%	$1.16B
21. Bowman Consulting Group Ltd. (BWMN)	32.1%/yr	2.6%	$547.20M
22. Postal Realty Trust, Inc. (PSTL)	31.4%/yr	14.8%	$831.72M
23. Kimbell Royalty Partners, LP (KRP)	28.9%/yr	28.2%	$1.68B
24. Gogo Inc. (GOGO)	27.5%/yr	1.4%	$463.19M
25. Stagwell Inc. (STGW)	26.8%/yr	1.0%	$1.59B

Criteria are deterministic filters over filed annual statements — no editorial picks, no payment for placement. Not investment advice.

Ask the AI analyst about any of these

Every figure it cites comes straight from SEC filings, with the sources shown — never AI guesswork. Put this leaderboard to work:

Is ORRF a good buy? → ORRF vs CFFN → Rank the top 3 →

Try the AI analyst free — no card

Run your own screen — free

The full screener covers 3,800+ US companies with growth, margin, ROE, valuation and dividend filters. No account needed.

Open the free screener

Small-Cap Growth Stocks in the US Market — frequently asked questions

How is the "Small-Cap Growth Stocks in the US Market" list calculated?

Companies under $2B in market value compounding revenue 15%+ a year with positive free cash flow — fast growers that are also self-funding. The ranking is produced by a deterministic filter over companies' SEC-filed annual statements, re-run every night — no editorial picks and no paid placement. 58 companies pass the filter today; the top 25 are shown.

What is the top-ranked stock in this screen right now?

As of the latest nightly refresh, Orrstown Financial Services, Inc. (ORRF) ranks first, with rev growth (5y) of 72.1%/yr. The full ranked list of 25 companies is in the table above, and you can re-run or adjust the filters yourself in the free screener.

How often is this list updated?

It is recomputed every night from the latest SEC filing data, so newly filed 10-Ks and 10-Qs flow into the ranking on the next build. The figures reflect what companies have actually reported, not analyst forecasts.

Is this investment advice?

No. This is a factual, rules-based screen of filed fundamentals for research and education only — not a recommendation to buy or sell any security. Always verify against the primary filing and consider your own circumstances before investing.

More screens